Navidea Biopharmaceuticals (NAVB) To Present At The 9th Annual JMP Securities Healthcare Conference
6/18/2014 11:23:51 AM
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Michael Goldberg, M.D., Interim Chief Executive Officer, will participate at the 9th Annual JMP Securities Healthcare Conference June 24-25, 2014 at the Westin New York Grand Central in New York City, NY. Navidea’s presentation is on Tuesday, June 24, 2014 at 2:00 PM EDT.
Help employers find you! Check out all the jobs and post your resume.
comments powered by